
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Gene knockout (KO) cell lines are engineered cellular models in which the function of a specific target gene has been completely ablated using advanced genome editing technologies. This powerful tool allows researchers to investigate gene function, validate drug targets, and model genetic diseases by establishing a direct causal link between gene loss and phenotypic outcome. Utilizing state-of-the-art platforms like CRISPR/Cas9, our service provides reliable, high-efficiency generation of knockout cell lines to accelerate your research in basic science, drug discovery, and therapeutic development.
Gene knockout can be achieved through several established methodologies. While homologous recombination and RNA interference (RNAi) have historical significance, CRISPR/Cas9-mediated genome editing is now the gold standard for creating permanent, specific gene knockouts due to its unparalleled precision and efficiency.
The CRISPR-Cas9 system utilizes a designed single-guide RNA (sgRNA) to direct the Cas9 nuclease to a precise location within your target gene, inducing a double-strand break (DSB). The cell primarily repairs this break via the non-homologous end joining (NHEJ) pathway. NHEJ is an error-prone process that often introduces small insertions or deletions (indels) at the break site. These mutations frequently disrupt the reading frame or create premature stop codons, leading to complete loss of functional protein expression and a successful gene knockout.
We guide your project from concept to validated cell line with a rigorous, optimized workflow:

Strategy & sgRNA Design: Our experts analyze your target gene to design and select highly efficient, specific sgRNAs, minimizing off-target effects.
Vector Construction & Delivery: We clone sgRNAs into optimized CRISPR vectors and introduce them into your chosen cell line via advanced methods like electroporation or viral transduction.
Editing & Screening: Post-delivery, cells are screened for indels using PCR-based genotyping (T7E1, Surveyor assay) or Sanger sequencing to identify a successfully edited polyclonal population.
Monoclonal Cell Line Generation: We perform single-cell cloning via limiting dilution or FACS sorting to isolate pure, genetically uniform clonal populations.
Rigorous Validation: Each clonal line undergoes multi-level validation, including:
Knockout cell lines are indispensable tools across the life sciences:
Gene knockout cell line technology is a foundational pillar of modern biology, enabling definitive causal inference from genotype to phenotype. Whether your goal is to unravel a fundamental biological mechanism, validate a promising drug target, or engineer the next generation of cell therapies, a precisely engineered knockout model is the critical first step.
Contact us today to discuss your specific gene knockout project and receive a detailed proposal. Let our expertise in precision genome editing become the cornerstone of your next discovery.
Contact Email: sales@reqbio.com
If you are interested in ordering, please contact us.
Customer help-line
4008-750-250
sales@reqbio.com
Office address:
3rd Floor, No. 6, Lane 222, Guangdan Road, Pudong New Area, Shanghai, China
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
Explore